RecruitingNCT06928545

MagDI U.S. Registry

Post-Market Assessment of the Incidence and Severity of Internal Hernia and Bowel Obstruction at One Year Following Use of the MagDI System to Create Side-to-Side Duodeno-Ileal Magnetic Compression Anastomoses (MagDI US Registry)


Sponsor

GT Metabolic Solutions, Inc.

Enrollment

106 participants

Start Date

Mar 28, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Assess the incidence and severity of internal hernia and bowel obstruction at one year in a U.S. population following use of the MagDI System to create side-to-side duodeno-ileal anastomoses.


Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Side-to-side duodenal-ileal anastomosis for people with anastomosis, surgical, bowel obstruction, and other related conditions. The study is currently recruiting participants at 5 locations. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESide-to-side duodenal-ileal anastomosis

Side-to-side duodenal-ileal anastomosis formed by magnetic compression using the GT Metabolic MagDI System.


Locations(6)

Ventura Advanced Surgical Associates

Ventura, California, United States

HCA Florida Mercy

Miami, Florida, United States

Baptist Healthcare System, Inc.

Louisville, Kentucky, United States

Ochsner Clinic Foundation

Lafayette, Louisiana, United States

Bariatric Specialists of the Carolinas

Cary, North Carolina, United States

Transform Weight Loss

Lynnwood, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06928545


Related Trials